-
1
-
-
0031034624
-
The british guidelines on asthma management. 1995 Review and position statement
-
British Thoracic Society, National Asthma Campaign, Royal College of Physicians of London et al. The British Guidelines on asthma management. 1995 Review and Position Statement. Thorax 1997; 52 (Suppl. 1):S1-S21.
-
(1997)
Thorax
, vol.52
, Issue.SUPPL. 1
-
-
-
2
-
-
0029914052
-
Undertreatment in a nonselected population of adult patients with asthma
-
Bousquet J, Knani J, Henry C et al. Undertreatment in a nonselected population of adult patients with asthma. J Allergy Clin Immunol 1996; 98:514-21.
-
(1996)
J Allergy Clin Immunol
, vol.98
, pp. 514-521
-
-
Bousquet, J.1
Knani, J.2
Henry, C.3
-
3
-
-
0032986796
-
Morbidity from asthma in relation to regular treatment: A community based study
-
Walsh LJ, Wong CA, Cooper S, Guhan AR, Pringle M, Tattersfield AE. Morbidity from asthma in relation to regular treatment: a community based study. Thorax 1999; 54:296-300.
-
(1999)
Thorax
, vol.54
, pp. 296-300
-
-
Walsh, L.J.1
Wong, C.A.2
Cooper, S.3
Guhan, A.R.4
Pringle, M.5
Tattersfield, A.E.6
-
4
-
-
0032938331
-
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment
-
The AMPUL Study Group
-
Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbrouke JP, Sterk PJ. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999; 159:1043-51.
-
(1999)
Am J Respir Crit Care Med
, vol.159
, pp. 1043-1051
-
-
Sont, J.K.1
Willems, L.N.2
Bel, E.H.3
Van Krieken, J.H.4
Vandenbrouke, J.P.5
Sterk, P.J.6
-
5
-
-
0033574195
-
Oral montelukast, inhaled beclomethasone and placebo for chronic asthma. A randomized controlled trial
-
Montelukast/Beclomethasone Study Group
-
Malmstrom K, Rodriguez-Gomez G, Guerra J et al. Oral montelukast, inhaled beclomethasone and placebo for chronic asthma. A randomized controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med 1999; 130:487-95.
-
(1999)
Ann Intern Med
, vol.130
, pp. 487-495
-
-
Malmstrom, K.1
Rodriguez-Gomez, G.2
Guerra, J.3
-
6
-
-
1842370350
-
Effect of inhaled formoterol and budesonide on exacerbations of asthma
-
Formoterol and corticosteroids Establishing Therapy (FACET) International Study Group
-
Pauwels RA, Lofdahl CG, Postma DS et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and corticosteroids Establishing Therapy (FACET) International Study Group. New Engl J Med 1997; 337:1405-11.
-
(1997)
New Engl J Med
, vol.337
, pp. 1405-1411
-
-
Pauwels, R.A.1
Lofdahl, C.G.2
Postma, D.S.3
-
7
-
-
0028264310
-
Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
-
Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344:219-24.
-
(1994)
Lancet
, vol.344
, pp. 219-224
-
-
Greening, A.P.1
Ind, P.W.2
Northfield, M.3
Shaw, G.4
-
8
-
-
0033025989
-
Difficult/therapy-resistant asthma: The need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies
-
Chung KF, Godard P. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. Eur Repair J 1999; 13:1198-1208.
-
(1999)
Eur Repair J
, vol.13
, pp. 1198-1208
-
-
Chung, K.F.1
Godard, P.2
|